Matrixx Investors Get Class Cert. In Suit Over Zicam Effects

Law360, Washington (August 1, 2012, 2:27 PM EDT) -- An Arizona federal judge on Tuesday certified a class of Matrixx Initiatives Inc. shareholders who claim the company concealed hundreds of reports that its cold remedy Zicam products caused users to lose their sense of smell, which artificially inflated its stock price.

Matrixx previously balked at the certification request, saying the class couldn't allege it didn't know that there were reports of anosmia associated with Zicam use. The company also claimed that the proposed lead plaintiff, Alex Alegre de La Soujeole, could not adequately represent the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.